MX367861B - Una composición nutricional para usarse en la preservación del músculo esquelético. - Google Patents

Una composición nutricional para usarse en la preservación del músculo esquelético.

Info

Publication number
MX367861B
MX367861B MX2015004181A MX2015004181A MX367861B MX 367861 B MX367861 B MX 367861B MX 2015004181 A MX2015004181 A MX 2015004181A MX 2015004181 A MX2015004181 A MX 2015004181A MX 367861 B MX367861 B MX 367861B
Authority
MX
Mexico
Prior art keywords
egcg
muscle loss
skeletal muscle
mitigating
enhancing
Prior art date
Application number
MX2015004181A
Other languages
English (en)
Other versions
MX2015004181A (es
Inventor
Pereira Suzette
Garvey Sean
Edens Neile
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49354981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX367861(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2015004181A publication Critical patent/MX2015004181A/es
Publication of MX367861B publication Critical patent/MX367861B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)

Abstract

La presente invención se refiere a una composición nutricional para preservar la función del músculo esquelético en un sujeto susceptible a la pérdida de función del músculo esquelético debida al envejecimiento, inactividad o enfermedad, la composición nutricional comprende por lo menos una fuente de galato de epigalocatequina (EGCg), y por lo menos una fuente de zinc.
MX2015004181A 2012-10-04 2013-10-04 Una composición nutricional para usarse en la preservación del músculo esquelético. MX367861B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261709682P 2012-10-04 2012-10-04
PCT/US2013/063519 WO2014055905A1 (en) 2012-10-04 2013-10-04 Methods for enhancing the effect of egcg on mitigating skeletal muscle loss

Publications (2)

Publication Number Publication Date
MX2015004181A MX2015004181A (es) 2015-06-10
MX367861B true MX367861B (es) 2019-09-09

Family

ID=49354981

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015004181A MX367861B (es) 2012-10-04 2013-10-04 Una composición nutricional para usarse en la preservación del músculo esquelético.

Country Status (12)

Country Link
US (2) US9579347B2 (es)
EP (1) EP2903458B1 (es)
JP (1) JP2015532104A (es)
CN (2) CN107048383A (es)
BR (1) BR112015007131A2 (es)
CA (1) CA2885388C (es)
ES (1) ES2694426T3 (es)
HK (1) HK1212560A1 (es)
MX (1) MX367861B (es)
PH (1) PH12015500756A1 (es)
SG (1) SG11201502649WA (es)
WO (1) WO2014055905A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144458A1 (en) * 2013-03-15 2014-09-18 Abbott Laboratories Methods of maintaining and improving muscle function
WO2016044272A1 (en) * 2014-09-16 2016-03-24 Abbott Laboratories Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract
NL2015032B1 (en) * 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.
BR112018007434A2 (pt) 2015-10-27 2018-10-23 Cytozyme Animal Nutrition Inc composições para nutrição animal, usos e métodos relacionados
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN105901335A (zh) * 2016-05-25 2016-08-31 中国农业大学 一种促进猪骨骼肌生长的饲料添加剂及其应用
US10485502B2 (en) * 2016-12-20 2019-11-26 General Electric Company System and method for assessing muscle function of a patient
MX2019011725A (es) 2017-03-31 2020-07-28 Abbott Lab Composiciones nutricionales liquidas que contienen aceite de pescado oxidable, acido rosmarinico y hierro ferrico.
WO2018221526A1 (ja) * 2017-06-01 2018-12-06 株式会社明治 栄養組成物
US20200163370A1 (en) 2017-08-03 2020-05-28 Abbott Laboratories Liquid nutritional compositions including green tea extract and iron
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108094772A (zh) * 2017-12-08 2018-06-01 桂林莱茵生物科技股份有限公司 一种罗汉果果汁及其制备方法
AU2019224003A1 (en) * 2018-02-20 2020-10-08 Epirium Bio Inc. Compounds and compositions for the treatment of muscular disorders
KR102216599B1 (ko) * 2018-11-30 2021-02-16 (주)정옥 근감소증 개선을 위한 녹차추출물 함유 다슬기 추출 분말 제조방법 및 이를 이용한 다슬기 추출 분말
KR102240426B1 (ko) * 2018-11-30 2021-04-14 재단법인 하동녹차연구소 녹차추출물을 이용한 다슬기 추출방법 및 이를 이용한 다슬기 추출물
CN111000233A (zh) * 2019-11-28 2020-04-14 湖南农业大学 Ecg作为健肌功能成分的应用
JP7407643B2 (ja) * 2020-04-02 2024-01-04 サントリーホールディングス株式会社 中鎖脂肪酸トリグリセリドとアスコルビン酸とを含有する加熱殺菌済み容器詰め飲料
WO2022165263A1 (en) * 2021-01-29 2022-08-04 Uqora, Inc. Compositions and methods for treating bacterial infections
WO2022266359A1 (en) * 2021-06-17 2022-12-22 Ocean Spray Cranberries, Inc. Rare sugars in food and beverage products

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455059A (en) * 1993-10-15 1995-10-03 Nabisco, Inc. Fat-free toppings and fillings for bakery products
IT1299197B1 (it) 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
US6509054B1 (en) * 2000-05-05 2003-01-21 American Fruits And Flavors Food additives having enlarged concentration of phenolics extracted from fruits, and process of obtaining the same
US20020122835A1 (en) 2001-03-01 2002-09-05 Bucci Luke R. Compositions for enhancing muscle tissue recovery and repair
US7026298B2 (en) 2001-06-04 2006-04-11 Abbott Laboratories Oral rehydration compositions
JP2005501833A (ja) 2001-07-30 2005-01-20 ディーエスエム アイピー アセッツ ビー.ブイ. エピガロカテキンガレートのための組成物
BRPI0412297A (pt) 2003-07-03 2006-09-19 Procter & Gamble composições contendo catequinas de chá verde e um ou mais cátions minerais polivalentes
FR2861594B1 (fr) 2003-11-03 2006-01-20 Baudry Jacquet Composition contenant un extrait de the vert et de la vitamine c
CA2566343C (en) 2004-05-07 2013-07-09 Thermo Formulations Ltd. Nutritional composition for increasing creatine uptake in skeletal muscle
WO2005110122A1 (en) * 2004-05-18 2005-11-24 Dsm Ip Assets B.V. USE OF β-CRYPTOXANTHIN
US20050260302A1 (en) * 2004-05-19 2005-11-24 The Procter & Gamble Company Nutritionally balanced traditional snack foods having a low glycemic response
US20060188548A1 (en) 2004-12-14 2006-08-24 Mattson Peter H Satiety promoting beverage and use in a diet to moderate food consumption
JP2006188436A (ja) 2004-12-28 2006-07-20 Japan Science & Technology Agency 医用ポリフェノール溶液
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
US20060239987A1 (en) 2005-04-22 2006-10-26 Robert Foster Nutritional composition and methods of making and using same
EP1904070A4 (en) 2005-07-07 2009-09-02 H3 Formulations Ltd NUTRITIONAL SUPPLEMENT FOR IMPROVING SKELETAL MUSHROOMS, REDUCING MUSCLE PROTEIN DEGRADATION, DOWNGRADING MUSCLE CATABOLISM PATHS, AND REDUCING CATABOLISM OF MUSCLE CELLS
CN100435790C (zh) * 2005-09-05 2008-11-26 中山大学 (-)-表没食子儿茶素没食子酸酯-锌络合物固体分散体及其制备方法与应用
CN101312718A (zh) * 2005-10-14 2008-11-26 帝斯曼知识产权资产管理有限公司 用于治疗肌肉消瘦的营养药物性组合物
CN101978958A (zh) 2005-10-14 2011-02-23 帝斯曼知识产权资产管理有限公司 用于治疗肌肉消瘦的营养药物性组合物
US8962678B2 (en) * 2006-07-05 2015-02-24 Kao Corporation Senescence inhibitor
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
CN101484157B (zh) 2006-07-05 2012-02-29 花王株式会社 肌肉力量提高剂
ITMI20061854A1 (it) 2006-09-28 2008-03-29 Genalta S R L Bevanda atta a rallentare la degenerazione cellulare che accompagna l'invecchiamento
EP1961310A1 (en) * 2007-02-01 2008-08-27 DSMIP Assets B.V. Novel use of (-) -epigallocatechin gallate
US20080193601A1 (en) 2007-02-10 2008-08-14 Nasser Faik A Protein-containing beverage and method of manufacture
US20080233245A1 (en) 2007-03-19 2008-09-25 Lesley Joan White Liquid nutrient composition for improving performance
US7989007B2 (en) 2007-07-03 2011-08-02 Vincent James Enterprises, Llc Weight loss composition
WO2009016018A1 (en) 2007-08-02 2009-02-05 Unilever Plc Compositions comprising polyphenol
US20100129467A9 (en) 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
US20090176312A1 (en) * 2007-12-04 2009-07-09 Selinfreund Richard H Biological and chemical test media and system
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
CA2746420C (en) * 2008-12-09 2019-11-12 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
BR112012001488A2 (pt) * 2009-07-20 2019-10-08 Nestec Sa processos de atenuação de perda de status funcional.
WO2011078654A1 (en) * 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
JP2013126951A (ja) * 2010-03-01 2013-06-27 Kyushu Univ 筋萎縮阻害剤
JP2011225475A (ja) 2010-04-16 2011-11-10 Celeste Inter Cooperation 筋萎縮抑制剤及び筋成長促進剤
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
US9486003B2 (en) 2010-06-28 2016-11-08 Nestec S.A. Hypocaloric, high protein nutritional compositions and methods of using same
WO2012097061A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
JP5438784B2 (ja) 2011-02-10 2014-03-12 ロート製薬株式会社 筋萎縮抑制剤及び筋成長促進剤
JP2012180331A (ja) * 2011-03-03 2012-09-20 Meiji Co Ltd 筋損傷の早期回復の誘導用の経口摂取剤
CN102224953B (zh) * 2011-04-27 2012-10-17 陈石良 一种丰胸美乳保健饮料

Also Published As

Publication number Publication date
CN104837369A (zh) 2015-08-12
CA2885388A1 (en) 2014-04-10
PH12015500756A1 (en) 2015-05-25
SG11201502649WA (en) 2015-05-28
CN107048383A (zh) 2017-08-18
WO2014055905A1 (en) 2014-04-10
JP2015532104A (ja) 2015-11-09
BR112015007131A2 (pt) 2017-07-04
CN104837369B (zh) 2017-03-08
EP2903458A1 (en) 2015-08-12
HK1212560A1 (zh) 2016-06-17
CA2885388C (en) 2018-01-02
US20170165297A1 (en) 2017-06-15
EP2903458B1 (en) 2018-09-05
US20150265650A1 (en) 2015-09-24
MX2015004181A (es) 2015-06-10
ES2694426T3 (es) 2018-12-20
US9579347B2 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
PH12015500756A1 (en) Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
MX2021010033A (es) Composiciones microencapsuladas de cannabinoides.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
EA030970B8 (ru) Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения
PH12019550096A1 (en) Beta-casein a2 and prevention of inflammation of the bowel
PH12015500900A1 (en) A stabilized pemetrexed formulation
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
PH12015502167A1 (en) Methods of maintaining and improving muscle function
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
IL215592A (en) Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
MX342947B (es) Tratamiento de diabetes tipo 2.
EP2557927A4 (en) FUNGICIDAL MIXTURES I WITH CHINAZOLINES
MX2015015197A (es) Vendaje para herida que comprende una composicion antimicrobiana.
MX2012012776A (es) Composicion de quitosano.
WO2012002730A3 (ko) 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물
MX2021016114A (es) Formulaciones para estabilizar la humedad en alimentos musculares.
PH12015501358A1 (en) Porous composition comprising salt and edible fat
MX2013002658A (es) Tratamiento fungicida, bactericida y/o antioxidante de articulos alimentarios por aplicacion de formulaciones que comprenden aceite esencial y un dialquilenglicol.
PH12015500704A1 (en) Pharmaceutical composition comprising rebamipide
EP2576536A4 (en) INHIBITORS OF HEMATOPOIETIC PROSTAGLANDIN D2 SYNTHASE
WO2013162933A3 (en) Active halogen antimicrobial composition and method of use
GB2521979A (en) A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
MX345263B (es) Formulación de pexiganan estable.
WO2014031982A3 (en) Methods and compositions for treating pain

Legal Events

Date Code Title Description
FG Grant or registration